Pulmonary agents

ALTIVIA Expands Capacity for Specialty Chemicals

Retrieved on: 
Wednesday, April 24, 2019
Chemistry, Physical sciences, Natural sciences, Pulmonary agents, Acyl chlorides, Oxohalides, Functional groups, Phosgene, Chlorine, Chloroformate

HOUSTON, April 24, 2019 /PRNewswire/ --ALTIVIA announced today the completion of a new multipurpose production unit at its Phosgene Derivatives Unit at La Porte, Texas.

Key Points: 
  • HOUSTON, April 24, 2019 /PRNewswire/ --ALTIVIA announced today the completion of a new multipurpose production unit at its Phosgene Derivatives Unit at La Porte, Texas.
  • This new facility will result in a 30% increase in capacity for the production of acid chlorides and chloroformates.
  • CAC is a key intermediate utilized for the production of pharmaceuticals and agricultural chemicals.
  • Headquartered in Houston, Texas, privately held ALTIVIA was founded in 1986 and today is the largest merchant producer of Phosgene derivative intermediates in the Americas.

Global Phosgene Market 2018-2022: Rising Investments in Infrastructure Development

Retrieved on: 
Friday, May 11, 2018
Chemistry, Economy, Pulmonary agents, Oxohalides, Phosgene, Marketplace, Compound annual growth rate, Market analysis

The "Global Phosgene Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Phosgene Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
  • The global phosgene market to grow at a CAGR of 5.25% during the period 2018-2022.
  • Global Phosgene Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts.
  • The report also includes a discussion of the key vendors operating in this market.